Ignite Creation Date:
2024-05-06 @ 3:57 PM
Last Modification Date:
2024-10-26 @ 2:00 PM
Study NCT ID:
NCT04811560
Status:
RECRUITING
Last Update Posted:
2024-05-23
First Post:
2021-03-22
Brief Title:
A Phase 12 Study of Bleximenib in Participants With Acute Leukemia
Sponsor:
Janssen Research Development LLC
Organization:
Janssen Research Development LLC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Acute Leukemias |
| Acute Myeloid Leukemia |
| Acute Lymphoblastic Leukemia |
Keywords: